Medik8, the brand behind the world's top retinal serum, has launched Exo-PDRN Prismatic+, a new skincare serum that promises visible results in just seven days. the product, which contains a high-strength exosome complex and GF MiniProtein, aims to reduce wrinkles,even skin tone, and boost luminosity.

The $30 million toe in the water

Medik8's Exo-PDRN Prismatic+ is a 30ml serum priced at $30 million, reflecting the brand's confidence in its revolutionary formula. The product is designed to work with the skin's natural repair process, improving resilience and visble rejuvenation.. According to the report, clinical studies have porven positive results within just seven days, making it a game-changer in the skincare industry.

Why 4,000 unsold units became the prize

Despite its high price tag, Medik8's Exo-PDRN Prismatic+ has been widely acclaimed amongst skincare fans. The product's rapid results and high-strength exosome complex have made it a sought-after item, with 4,000 units already sold out. The report says that the serum's unique formula, which includes an ATP precursor, helps boost visible rejuvenation for smoother, more refreshed skin.

An echo of Sydney's 2024 institutional buy-up

The launch of Medik8's Exo-PDRN Prismatic+ comes at a time when the skincare industry is seeing a surge in demand for products that offer rapid results.. This trend echoes the institutional buy-up seen in Sydney in 2024, where skincare products with proven clinical results were in high demand.. As the report notes, Medik8's new serum is part of this broader trend, offering consumers a product that delivers visible improvements in just seven days.

Who is the unnamed buyer?

While Medik8's Exo-PDRN Prismatic+ has been widely acclaimed, the report does not disclose the identity of the unnamed buyer who purchased the 4,000 units. This raises questions about the product's accessibility and whether it will remain a high-end item or become more widely available. The report also does not provide information on the long-term effects of the serum , leaving consumers to wonder about its sustained benefits.